世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界の幹細胞市場

Global Stem Cell Market

 

出版社 出版年月電子版価格 ページ数
Market Litmus
マーケットリトマス
2018年6月US$3,850
シングルユーザライセンス
201

サマリー

この調査レポートは世界の幹細胞市場詳細に調査・分析したMarket Litmusの市場調査報告書です。

Overview

By 2022, the Global Stem Cell Market is estimated to reach US$ XX Mn, up from US$ XX Mn in 2016, growing at a CAGR of XX% during the forecast period.A stem cell is an undifferentiated biological cell that has the potential to develop into specialized cell types in the body. Given their unique regenerative abilities, stem cells offer prospective treatments for neurodegenerative diseases and conditions such as diabetes, heart diseases, and brain injuries. The most widely used stem cell treatment is the transplantation of blood stem cells to treat diseases and conditions of the blood and immune system. In addition to enabling regenerative medicine, stem cell research also promises to enhance drug discovery and development. Important clinical trials are underway and researches continue to explore new avenues for using stem cells in medicine.

End-users

The end-users of the stem cell market are hospitals, cell banks, clinical research laboratories, and academic institutes.

Market Dynamics

The global stem cell market is one of the most promising markets in the field of medicine and is expected to grow even more in the forecast period as stem cells enable cost-effective treatment of many conditions that currently have poor or no treatment. To address the increasing demand for stem cell banking services and regenerative treatment, scientists are engaged in discovering novels methods to produce human stem cells. Factors such as growing awareness related to the therapeutic potential of stem cells in disease management, increase in the patient population, rising investments in research and government support are expected to further accelerate the development of regenerative medicine, thus driving the market growth.

Whilethe market has ample scope for growth, factors such as high cost, regulatory policies, and ethical framework restrain it as well. Moreover, the list of diseases for which stem cell treatment has been proven safe and effective is still very short. Despite these hurdles, stem cell therapy is believed to be the next major advancement in transforming healthcare.

Market Segmentation

The globalstem cellmarket is fragmented on the basis of cell type, therapeutic application, and technology.

Cell Type

--> Adult Stem Cells

--> Human Embryonic Stem Cells

--> Induced Pluripotent Stem Cells

--> Rat Neural Stem Cells

Therapeutic Application

--> Musculoskeletal Disorders

--> Wounds and Injuries

--> Cardiovascular Diseases

--> Surgeries

--> Gastrointestinal diseases

Technology

--> Stem Cell Acquisition

--> Stem Cell Production

--> Stem Cell Cryopreservation

--> Stem Cell Expansion

Geographical Analysis

The North American region is by far the largest stakeholder in the global stem cell market and is expected to continue its dominance across the globe. The European Market, segmented into the United Kingdom, Germany, France, Italy, Spain, and rest of Europe, is the second leading market for stem cells. However, due to increasing awareness among the public and advances in technology, the market in Asia-Pacific is expected to grow at a high rate.

Key Players

Companies like Osiris Therapeutics Inc. (U.S.), NuVasive Inc. (U.S.), AlloSource (U.S.), RTI Surgical, Inc. (U.S.), Medipost Co. Ltd. (South Korea), Anterogen Co. Ltd. (South Korea), Pharmicell Co. Ltd. (South Korea), HolostemTerapieAvanzate(Italy), and JCR Pharmaceuticals Co. Ltd. (Japan) are some of the key players operating in the global stem cell therapy market.

Report Contents:

> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players

Regional Analysis:

> North America

>> US and Canada


> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America


> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe


> Eastern Europe

>> Russia
>> Poland
>> Rest of Eastern Europe


> Asia Pacific

>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific


> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa



This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

Report Highlights:

> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage



目次

目次はデータリソースまでお申し付けください。

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る